Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT "The Spirit Molecule"
Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment
Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
Forte Minerals Corp Exhibits at PDAC 2026, Highlighting the Alto Ruri Project's High-Grade Potential Near Barrick's Pierina Mine
NextSource Materials Announces Closing of $25 Million LIFE Offering to Advance UAE Battery Anode Facility
Canadian Securities Exchange Approves Gold Runner Exploration's Option to Acquire the Golden Girl Property from the B-ALL Syndicate in British Columbia's Prolific Golden Triangle
